Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital

被引:30
作者
Bubonja-Sonje, Marina [1 ,2 ]
Matovina, Mihaela [1 ]
Skrobonja, Ivana [2 ]
Bedenic, Branka [3 ,4 ]
Abram, Maja [1 ,2 ]
机构
[1] Univ Rijeka, Fac Med, Dept Microbiol, Rijeka 51000, Croatia
[2] Clin Hosp Ctr Rijeka, Dept Clin Microbiol, Rijeka, Croatia
[3] Univ Zagreb, Sch Med, Dept Microbiol, Zagreb 41001, Croatia
[4] Univ Hosp Ctr Zagreb, Clin Dept Clin & Mol Microbiol, Zagreb, Croatia
关键词
METALLO-BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; IMIPENEM RESISTANCE; INTENSIVE-CARE; RISK-FACTORS; PORIN OPRD; INFECTION; OUTBREAK; GENE; SUSCEPTIBILITY;
D O I
10.1089/mdr.2014.0172
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pseudomonas aeruginosa is an opportunistic pathogen, one of the leading causes of nosocomial infections such as pneumonia, urinary tract infections, and bacteraemia. The bacterial resistance to structurally unrelated antibiotics and its spread within hospitals limits the efficient antimicrobial options and patients' outcome. Carbapenems are important agents for the therapy of infections due to multidrug-resistant (MDR) P. aeruginosa; hence, the development of carbapenem resistance severely hampers effective therapeutic options. The aim of this investigation was to examine mechanisms of carbapenem resistance and genomic diversity in carbapenem-resistant MDR strains of P. aeruginosa, which caused an outbreak among patients in Clinical Hospital Rijeka. Most of the isolates showed decreased expression of porin that is important for the entry of carbapenems (oprD). Overexpression of MexAB-OprM, MexCD-OprJ, and MexEF-OprN efflux systems was observed in many of the isolates. Production of metallo--lactamases was not detected. Typing by pulsed-field gel electrophoresis discriminated the isolates into five clusters. The clonal distribution of the strains was related to the location of hospital departments where the isolates were collected, which implies that most of the infections were caused by spread of the epidemic strains within the hospital.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 45 条
[1]   Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit [J].
Aumeran, C. ;
Paillard, C. ;
Robin, F. ;
Kanold, J. ;
Baud, O. ;
Bonnet, R. ;
Souweine, B. ;
Traore, O. .
JOURNAL OF HOSPITAL INFECTION, 2007, 65 (01) :47-53
[2]  
Blanc D S, 2007, Open Microbiol J, V1, P8, DOI 10.2174/1874285800701010008
[3]   VIM-2 β-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia [J].
Bosnjak, Zrinka ;
Bedenic, Branka ;
Mazzariol, Annarita ;
Jarza-Davila, Neda ;
Suto, Sandra ;
Kalenic, Smilja .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (03) :193-197
[4]   Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study [J].
Cabot, Gabriel ;
Ocampo-Sosa, Alain A. ;
Tubau, Fe ;
Macia, Maria D. ;
Rodriguez, Cristina ;
Moya, Bartolome ;
Zamorano, Laura ;
Suarez, Cristina ;
Pena, Carmen ;
Martinez-Martinez, Luis ;
Oliver, Antonio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) :1906-1911
[5]   Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase [J].
Castanheira, M ;
Toleman, MA ;
Jones, RN ;
Schmidt, FJ ;
Walsh, TR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4654-4661
[6]   Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study [J].
Cook, Paul P. ;
Gooch, Michael ;
Rizzo, Shemra .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) :5597-5601
[7]   Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection [J].
Defez, C ;
Fabbro-Peray, P ;
Bouziges, N ;
Gouby, A ;
Mahamat, A ;
Daurès, JP ;
Sotto, A .
JOURNAL OF HOSPITAL INFECTION, 2004, 57 (03) :209-216
[8]  
El Amin N, 2005, APMIS, V113, P187, DOI 10.1111/j.1600-0463.2005.apm1130306.x
[9]  
European Centre for Disease Prevention and Control (ECDC), 2014, ANN EP REP REP 2011
[10]  
European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, BREAKP TABL INT MICS